Kim K - Search Results

1

A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site.

Maehigashi T, Ahn S, Kim UI, Lindenberger J, Oo A, Koneru PC, Mahboubi B, Engelman AN, Kvaratskhelia M, Kim K, Kim B. Maehigashi T, et al. Among authors: kim b, kim ui, kim k. PLoS Pathog. 2021 Jul 22;17(7):e1009671. doi: 10.1371/journal.ppat.1009671. eCollection 2021 Jul. PLoS Pathog. 2021. PMID: 34293041 Free PMC article.

2

Comparison of Antiviral Activity of Gemcitabine with 2'-Fluoro-2'-Deoxycytidine and Combination Therapy with Remdesivir against SARS-CoV-2.

Jang Y, Shin JS, Lee MK, Jung E, An T, Kim UI, Kim K, Kim M. Jang Y, et al. Among authors: kim ui, kim m, kim k. Int J Mol Sci. 2021 Feb 4;22(4):1581. doi: 10.3390/ijms22041581. Int J Mol Sci. 2021. PMID: 33557278 Free PMC article.

3

Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia.

Choi JU, Lee NK, Seo H, Chung SW, Al-Hilal TA, Park SJ, Kweon S, Min N, Kim SK, Ahn S, Kim UI, Park JW, Kang CY, Kim IS, Kim SY, Kim K, Byun Y. Choi JU, et al. Among authors: kim ui, kim sy, kim sk, kim is, kim k. J Immunother Cancer. 2021 Aug;9(8):e002332. doi: 10.1136/jitc-2021-002332. J Immunother Cancer. 2021. PMID: 34341129 Free PMC article.

4

Tankyrase-selective inhibitor STP1002 shows preclinical antitumour efficacy without on-target toxicity in the gastrointestinal tract.

Kim DY, Kwon YJ, Seo WY, Kim UI, Ahn S, Choi SM, Bang HT, Kim K, Kim JS. Kim DY, et al. Among authors: kim ui, kim js, kim k. Eur J Cancer. 2022 Sep;173:41-51. doi: 10.1016/j.ejca.2022.06.031. Epub 2022 Jul 15. Eur J Cancer. 2022. PMID: 35849876

5

Evaluation of Antiviral Activity of Gemcitabine Derivatives against Influenza Virus and Severe Acute Respiratory Syndrome Coronavirus 2.

Cha HM, Kim UI, Ahn SB, Lee MK, Lee H, Bang H, Jang Y, Kim SS, Bae MA, Kim K, Kim M. Cha HM, et al. Among authors: kim ss, kim ui, kim m, kim k. ACS Infect Dis. 2023 Apr 14;9(4):1033-1045. doi: 10.1021/acsinfecdis.3c00034. Epub 2023 Mar 13. ACS Infect Dis. 2023. PMID: 36912867 Free PMC article.

6

Novel piperazine-based ionizable lipid nanoparticles allow the repeated dose of mRNA to fibrotic lungs with improved potency and safety.

Kim M, Jeong M, Lee G, Lee Y, Park J, Jung H, Im S, Yang JS, Kim K, Lee H. Kim M, et al. Among authors: kim k. Bioeng Transl Med. 2023 May 28;8(6):e10556. doi: 10.1002/btm2.10556. eCollection 2023 Nov. Bioeng Transl Med. 2023. PMID: 38023699 Free PMC article.

7

End-Site-Specific Conjugation of Enoxaparin and Tetradeoxycholic Acid Using Nonenzymatic Glycosylation for Oral Delivery.

Park J, Jeon OC, Yun J, Nam H, Hwang J, Al-Hilal TA, Kim K, Kim K, Byun Y. Park J, et al. Among authors: kim k. J Med Chem. 2016 Dec 8;59(23):10520-10529. doi: 10.1021/acs.jmedchem.6b00936. Epub 2016 Nov 30. J Med Chem. 2016. PMID: 27933952

8

Structure-Activity Relationship and Functional Evaluation of Cannabinoid Type-1 Receptor.

Wang S, Tian X, Paudel S, Ghil S, Jang CG, Kim KM. Wang S, et al. Among authors: kim km. Biomol Ther (Seoul). 2024 Jun 7. doi: 10.4062/biomolther.2023.205. Online ahead of print. Biomol Ther (Seoul). 2024. PMID: 38844801

9

Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas.

Arrieta VA, Gould A, Kim KS, Habashy KJ, Dmello C, Vázquez-Cervantes GI, Palacín-Aliana I, McManus G, Amidei C, Gomez C, Dhiantravan S, Chen L, Zhang DY, Saganty R, Cholak ME, Pandey S, McCord M, McCortney K, Castro B, Ward R, Muzzio M, Bouchoux G, Desseaux C, Canney M, Carpentier A, Zhang B, Miska JM, Lesniak MS, Horbinski CM, Lukas RV, Stupp R, Lee-Chang C, Sonabend AM. Arrieta VA, et al. Among authors: kim ks. Nat Commun. 2024 Jun 6;15(1):4698. doi: 10.1038/s41467-024-48326-w. Nat Commun. 2024. PMID: 38844770

10

Very early vs delayed invasive strategy in high-risk NSTEMI patients without hemodynamic instability: Insight from the KAMIR-NIH.

Lee SD, Kim RB, Seo CO, Kim M, Lee HJ, Kim H, Kim HR, Kim K, Kang MG, Park JR, Hwang SJ, Hwang JY, Jeong MH, Hur SH, Cha KS, Koh JS; KAMIR-NIH registry investigators. Lee SD, et al. Among authors: kim k. PLoS One. 2024 Jun 6;19(6):e0304273. doi: 10.1371/journal.pone.0304273. eCollection 2024. PLoS One. 2024. PMID: 38843207 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

51,889 results

Search Page